UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Melatonin Treatment Enhances Aβ Lymphatic Clearance in a Transgenic Mouse Model of Amyloidosis

Current Alzheimer research, 2018-01, Vol.15 (7), p.637-642

2018

Volltextzugriff (PDF)

Molecular toxicity of aluminium in relation to neurodegeneration

Indian journal of medical research (New Delhi, India : 1994), 2008-10, Vol.128 (4), p.545

2008

Volltextzugriff (PDF)

A critical analysis of new molecular targets and strategies for drug developments in Alzheimer's disease

Current drug targets, 2003-02, Vol.4 (2), p.97-112

2003

Volltextzugriff (PDF)

Rationale for the development of cholinesterase inhibitors as anti-Alzheimer agents

Current pharmaceutical design, 2004-10, Vol.10 (25), p.3111-3119

2004

Volltextzugriff (PDF)

Resolution of inflammation is altered in Alzheimer's disease

Alzheimer's & dementia, 2015-01, Vol.11 (1), p.40-50.e2

2015

Volltextzugriff (PDF)

Selective Butyrylcholinesterase Inhibition Elevates Brain Acetylcholine, Augments Learning and Lowers Alzheimer β-Amyloid Peptide in Rodent

Proceedings of the National Academy of Sciences - PNAS, 2005-11, Vol.102 (47), p.17213-17218

2005

Volltextzugriff (PDF)

Cell‐free assays for γ‐secretase activity

The FASEB journal, 2000-12, Vol.14 (15), p.2383-2386

2000

Volltextzugriff (PDF)

High cholesterol-induced neuroinflammation and amyloid precursor protein processing correlate with loss of working memory in mice

Journal of neurochemistry, 2008-07, Vol.106 (1), p.475-485

2008

Volltextzugriff (PDF)

Effects of a saturated fat and high cholesterol diet on memory and hippocampal morphology in the middle-aged rat

Journal of Alzheimer's disease, 2008-06, Vol.14 (2), p.133-145

2008

Volltextzugriff (PDF)

Higher Incidence of Mild Cognitive Impairment in Familial Hypercholesterolemia

The American journal of medicine, 2010-03, Vol.123 (3), p.267-274

2010

Volltextzugriff (PDF)

Amyloid-β Peptide Levels in Brain Are Inversely Correlated with Insulysin Activity Levels in vivo

Proceedings of the National Academy of Sciences - PNAS, 2003-05, Vol.100 (10), p.6221-6226

2003

Volltextzugriff (PDF)

Differential Expression of Cholesterol Hydroxylases in Alzheimer's Disease

The Journal of biological chemistry, 2004-08, Vol.279 (33), p.34674-34681

2004

Volltextzugriff (PDF)

Hypercholesterolemia Accelerates the Alzheimer's Amyloid Pathology in a Transgenic Mouse Model

Neurobiology of disease, 2000-08, Vol.7 (4), p.321-331

2000

Volltextzugriff (PDF)

Butyrylcholinesterase: An Important New Target in Alzheimer's Disease Therapy

International psychogeriatrics, 2002-01, Vol.14 (S1), p.77-91

2002

Volltextzugriff (PDF)

Glucagon-like peptide-1 decreases endogenous amyloid-β peptide (Aβ) levels and protects hippocampal neurons from death induced by Aβ and iron

Journal of neuroscience research, 2003-06, Vol.72 (5), p.603-612

2003

Volltextzugriff (PDF)

Gene structure and organization of the human β‐secretase (BACE) promoter

The FASEB journal, 2004-06, Vol.18 (9), p.1034-1036

2004

Volltextzugriff (PDF)

Alzheimer's disease beta-amyloid peptide is increased in mice deficient in endothelin-converting enzyme

The Journal of biological chemistry, 2003-01, Vol.278 (4), p.2081-2084

2003

Volltextzugriff (PDF)

Convertases other than furin cleave β‐secretase to its mature form

The FASEB journal, 2001-08, Vol.15 (10), p.1810-1812

2001

Volltextzugriff (PDF)

Role of DNA dynamics in Alzheimer's disease

Brain Research Reviews, 2008-06, Vol.58 (1), p.136-148

2008

Volltextzugriff (PDF)

Reduction of Abeta accumulation in the Tg2576 animal model of Alzheimer's disease after oral administration of the phosphatidyl-inositol kinase inhibitor wortmannin

The FASEB journal, 2001-01, Vol.15 (1), p.16-18

2001

Volltextzugriff (PDF)

Apolipoprotein gene and its interaction with the environmentally driven risk factors: molecular, genetic and epidemiological studies of Alzheimer’s disease

Neurobiology of aging, 2004-05, Vol.25 (5), p.651-660

2004

Volltextzugriff (PDF)

Current drug targets for Alzheimer's disease treatment

Drug development research, 2002-07, Vol.56 (3), p.267-281

2002

Volltextzugriff (PDF)

Phenserine Regulates Translation of β-Amyloid Precursor Protein mRNA by a Putative Interleukin-1 Responsive Element, a Target for Drug Development

Proceedings of the National Academy of Sciences - PNAS, 2001-06, Vol.98 (13), p.7605-7610

2001

Volltextzugriff (PDF)

Geranylgeranyl pyrophosphate stimulates γ‐secretase to increase the generation of Aβ and APP‐CTFγ

The FASEB journal, 2008-01, Vol.22 (1), p.47-54

2008

Volltextzugriff (PDF)

The Role of the Carboxyl-Terminal Fragments of Amyloid Precursor Protein in Alzheimer's Disease

Annals of the New York Academy of Sciences, 2002-11, Vol.973 (1), p.334-339

2002

Volltextzugriff (PDF)

1 – 25 von 154

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(149)
Mit Volltextzugriff
(122)

Publikationsform

Artikel
(154)

Sprache

Englisch
(154)
Japanisch
(12)

Erscheinungsjahr

n.n

Thema

Science & Technology
(88)
Life Sciences & Biomedicine
(78)
Humans
(60)
Animals
(55)
Neurosciences & Neurology
(41)
Alzheimer's Disease
(38)
Neurosciences
(38)
Alzheimer Disease - Metabolism
(25)
Biochemistry & Molecular Biology
(24)
Amyloid Beta-Protein Precursor - Metabolism
(22)
Amyloid Beta-Peptides - Metabolism
(20)
Biological And Medical Sciences
(20)
Amyloid Precursor Protein Secretases
(17)
Mice
(17)
Neurology
(17)
Amyloid
(15)
Brain - Metabolism
(15)
Alzheimer Disease - Drug Therapy
(14)
Medical Sciences
(13)
Disease Models, Animal
(12)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Melatonin Treatment Enhances Aβ Lymphatic Clearance in a Transgenic Mouse Model of Amyloidosis

Molecular toxicity of aluminium in relation to neurodegeneration

A critical analysis of new molecular targets and strategies for drug developments in Alzheimer's disease

Rationale for the development of cholinesterase inhibitors as anti-Alzheimer agents

Resolution of inflammation is altered in Alzheimer's disease

Selective Butyrylcholinesterase Inhibition Elevates Brain Acetylcholine, Augments Learning and Lowers Alzheimer β-Amyloid Peptide in Rodent

Cell‐free assays for γ‐secretase activity

High cholesterol-induced neuroinflammation and amyloid precursor protein processing correlate with loss of working memory in mice

Effects of a saturated fat and high cholesterol diet on memory and hippocampal morphology in the middle-aged rat

Higher Incidence of Mild Cognitive Impairment in Familial Hypercholesterolemia

Amyloid-β Peptide Levels in Brain Are Inversely Correlated with Insulysin Activity Levels in vivo

Differential Expression of Cholesterol Hydroxylases in Alzheimer's Disease

Hypercholesterolemia Accelerates the Alzheimer's Amyloid Pathology in a Transgenic Mouse Model

Butyrylcholinesterase: An Important New Target in Alzheimer's Disease Therapy

Glucagon-like peptide-1 decreases endogenous amyloid-β peptide (Aβ) levels and protects hippocampal neurons from death induced by Aβ and iron

Gene structure and organization of the human β‐secretase (BACE) promoter

Alzheimer's disease beta-amyloid peptide is increased in mice deficient in endothelin-converting enzyme

Convertases other than furin cleave β‐secretase to its mature form

Role of DNA dynamics in Alzheimer's disease

Reduction of Abeta accumulation in the Tg2576 animal model of Alzheimer's disease after oral administration of the phosphatidyl-inositol kinase inhibitor wortmannin

Apolipoprotein gene and its interaction with the environmentally driven risk factors: molecular, genetic and epidemiological studies of Alzheimer’s disease

Current drug targets for Alzheimer's disease treatment

Phenserine Regulates Translation of β-Amyloid Precursor Protein mRNA by a Putative Interleukin-1 Responsive Element, a Target for Drug Development

Geranylgeranyl pyrophosphate stimulates γ‐secretase to increase the generation of Aβ and APP‐CTFγ

The Role of the Carboxyl-Terminal Fragments of Amyloid Precursor Protein in Alzheimer's Disease

Suchergebnisse filtern